Head and neck squamous cell carcinoma lines produce biologically active angiogenic factors

被引:35
作者
Shemirani, B [1 ]
Crowe, DL [1 ]
机构
[1] Univ So Calif, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA
关键词
squamous cell carcinoma; fibroblast growth factor; vascular endothelial growth factor; angiogenesis;
D O I
10.1016/S1368-8375(99)00052-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiogenesis is the formation of capillaries from pre-existing blood vessels. Angiogenesis occurs in many developmental, physiologic, and pathologic processes including tumor growth. Previous studies have shown that angiogenesis is required for growth and metastasis of solid tumors. Fibroblast growth factors (FGF-1, -2) and vascular endothelial growth factor (VEGF) are extremely potent angiogenesis inducers by stimulating the proliferation and migration of capillary endothelial cells. Expression of these factors is upregulated in many solid tumors and correlates with high vascularity, lymph node metastasis, and poor clinical prognosis. Few studies have examined whether established head and neck squamous cell carcinoma (SCC) lines produce biologically active angiogenic factors. By immunoprecipitation, we detected FGF and VEGF proteins in cellular lysates of SCC lines. We also detected FGF-I and -2 proteins in serum-free-conditioned medium from these lines. Conditioned medium from SCC lines significantly increased proliferation of human umbilical vein endothelial cells (HUVEC). This increased proliferation was abrogated by preincubation of conditioned medium with neutralizing antibodies to FGFs and VEGF. Conditioned medium from SCC lines also significantly stimulated HUVEC invasion across a reconstituted basement membrane. We concluded that head and neck SCC lines secrete biologically active angiogenic factors. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 35 条
[1]   Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways [J].
Arbiser, JL ;
Moses, MA ;
Fernandez, CA ;
Ghiso, N ;
Cao, YH ;
Klauber, N ;
Frank, D ;
Brownlee, M ;
Flynn, E ;
Parangi, S ;
Byers, HR ;
Folkman, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (03) :861-866
[2]   Biological roles of fibroblast growth factor-2 [J].
Bikfalvi, A ;
Klein, S ;
Pintucci, G ;
Rifkin, DB .
ENDOCRINE REVIEWS, 1997, 18 (01) :26-45
[3]  
Borgstrom P, 1996, CANCER RES, V56, P4032
[4]   Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490
[5]   Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442
[6]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25
[7]  
Folkman J, 1992, Semin Cancer Biol, V3, P65
[8]  
Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
[9]   Tumor induction of VEGF promoter activity in stromal cells [J].
Fukumura, D ;
Xavier, R ;
Sugiura, T ;
Chen, Y ;
Park, EC ;
Lu, NF ;
Selig, M ;
Nielsen, G ;
Taksir, T ;
Jain, RK ;
Seed, B .
CELL, 1998, 94 (06) :715-725
[10]   Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation [J].
Gille, J ;
Swerlick, RA ;
Caughman, SW .
EMBO JOURNAL, 1997, 16 (04) :750-759